Richard Soll shared insights with PharmAsia News on China’s pharma evolution, and the transition of WuXi from chemistry services to fully integrated technology and capability platform
Subscribe to WXPress
Receive our newsletter and information on upcoming events.
About WuXi XPress
WXPress is your window into the world of WuXi AppTec and our global partners.
Please reach out with any business inquires.